$22.35
-0.98-4.2%
Benzinga
Benzinga
Benzinga
화요일, 10월 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Tectonic Therapeutic (TECX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.36 | $-1.17 | $-1.11 | $-1.05 |
| Actual | $-1.18 | $-1.34 | $-1.03 | $-1.02 |
| Surprise | +13.2% | -14.5% | +7.21% | +2.86% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.24 | $-1.91 | $-1.44 | $-1.50 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.18 | $-1.36 | 13.2 % |
| Q1 | May 7, 2026 | $-1.34 | $-1.17 | -14.5 % |
| Q4 | Feb 26, 2026 | $-1.03 | $-1.11 | 7.21 % |
| Q3 | Nov 6, 2025 | $-1.02 | $-1.05 | 2.86 % |